Exhibit 12.01

Utah Medical Products, Inc.
Exhibit 12 to Registration Statement on Form S-3
Calculation of ratio of earnings to fixed charges pursuant to Item 503(d) of Regulation S-K
	Six months
	ended		Year ended December 31,
	6/30/2008		2007		2006		2005		2004		2003
Fixed charges
(a) interest expensed and capitalized	$	125,848	$	270,315	$	254,807	$	9,767	$	-	$	46,803
(b)  amortized premiums, discounts and caaitalized expenses related to indebtedness		-		-		-		-		-		-
(c) estimated interest within rental expense		28,372		56,048		54,998		53,972		54,191		52,748
(d)  preference security dividend requirements of subsidiaries		-		-		-		-		-		-
Total fixed charges	$	154,220	$	326,363	$	309,805	$	63,739	$	54,191	$	99,551
Earnings
Total of:
(a)  Pretax income from continuing operations:	$	5,629,874	$	12,038,193	$	12,417,535	$	10,214,223	$	16,117,471	$	33,852,443
(b)  fixed charges		154,220		326,363		309,805		63,739		54,191		99,551
(c)  amortization of capitalized interest		-		-		-		-		-		-
(d)  distrubuted income of equity investees		-		-		-		-		-		-
(e)  issuer's share of of pre-tax losses of equity investees		-		-		-		-		-		-
		5,784,094		12,364,556		12,727,340		10,277,962		16,171,662		33,951,994
Less:
(a)  interest capitalized		-		-		-		-		-		-
(b)  preference security dividend requiremtns of consolidated subsidiaries		-		-		-		-		-		-
(c)  minority interest in pre-tax income of subsidiaries that have not incurred fixed charges		-		-		-		-		-		-
		-		-		-		-		-		-
Total Earnings	$	5,784,094	$	12,364,556	$	12,727,340	$	10,277,962	$	16,171,662	$	33,951,994
Ratio of earnings to fixed charges		37.5		37.9		41.1		161.3		298.4		341.1